Trial intelligence / Profile preview

Pramipexole Adjuvant to Morphine in Renal Colic

NCT04160520Phase 2Completed

Sponsor
East Carolina University
Start
Oct 2019
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Renal colic comparing Standard dose of morphine and placebo with Pramipexole and half-standard dose of morphine (2 arms). Primary endpoints: Proportion of patients who have an effective analgesic response (defined as at least a 50% improvement in pain scores) at 120 minutes, Total dose of opioid received at 120 minutes and 1 more. Started Oct 2019; status: completed.

02

Drugs

pramipexole
03

Conditions

Renal colic

Beyond the preview

Go deeper on NCT04160520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04160520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call